MeiraGTx UK II Ltd
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for Achromatopsia (CNGA3) (NCT03758404) | MeiraGTx UK II Ltd | 2019-08-12 |
| A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia (NCT04043104) | MeiraGTx UK II Ltd | 2019-06-30 |
| Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR) (NCT03349242) | MeiraGTx UK II Ltd | 2017-12-19 |
Track MeiraGTx UK II Ltd automatically
Every clearance here is in the API, with alerts when new ones post.